To the Editor: A 69-year-old Indigenous Australian man, with no known Caucasian ancestry, presented in 2008 with a 7-week history of depigmentation of the face and neck, which was initially intensely pruritic and erythematous. He had neither a personal history nor family history of vitiligo, but a 2 mm thick, Clark level III, superficially spreading melanoma had been widely excised from his right lateral calf in 2001; results of a right inguinal sentinel node biopsy had been negative. In 2005, multiple small local recurrences on the right lower leg had been surgically removed. Two years later, further histologically confirmed local cutaneous and subcutaneous recurrences were excised, but new lesions continued to develop. His medical history included type 2 diabetes mellitus, hypertension, atrial fibrillation and coronary artery bypass grafting. He had no family history of melanoma.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Royal Prince Alfred Hospital, Sydney, NSW.
- 2 University of Sydney, Sydney, NSW.
- 3 Melanoma Institute Australia, Sydney, NSW.
- 1. Lendon AH, Bennett RC. Malignant melanoma in an Aboriginal. Med J Aust 1972; 2: 1486-1487.
- 2. Pearce RL. Subungual desmoplastic melanoma in an Aboriginal woman. Med J Aust 1995; 162: 611-612.
- 3. Ram M, Shoenfeld Y. Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality? Ann N Y Acad Sci 2007; 1110: 410-425.
- 4. Quaglino P, Marenco F, Osella-Abate S, et al. Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study. Ann Oncol. Epub 2009 Jul 21. http://annonc.oxfordjournals.org/cgi/content/abstract/mdp325 (abstract accessed Dec 2009).